Stuart Bressman focuses on a variety of corporate and capital markets transactions, including securities offerings, venture capital and other forms of private equity, as well as other types of finance transactions. He also advises clients with respect to general corporate and securities compliance and reporting matters.
Stuart has represented both underwriters and issuers in connection with numerous public and private offerings of securities of foreign and domestic companies, including initial and secondary offerings of equity and convertible securities, offerings of high-yield and investment-grade debt, shelf registrations and Rule 144A offerings. Stuart is also known as a leader and innovator in the area of alternative financing techniques, such as confidentially marketed public offerings (CMPOs), registered direct offerings (RDs) and private investments in public equity (PIPEs).
Recent representations include:
Lazard Capital Markets/Lazard Frères & Company, as underwriter/placement agent, in a number of public offerings of securities, as well as PIPEs and private placements, such as the offering by Sarepta Therapeutics of $118 million of Common Stock, the offering by Sangamo BioSciences of $60 million of Common Stock, the offering by Vanda Pharmaceuticals of $50 million of Common Stock, the offering by Novavax of $95 million of Common Stock and the offering by Ballard Power Systems, a Canadian company, of Units consisting of Common Stock and Warrants
Cowen and Company, as underwriter/placement agent in several public offerings of securities, as well as PIPEs and private placements, including an offering of Common Stock and Warrants by Real Goods Solar
JP Morgan Securities in an offering of $323 million of Common Stock by ARIAD Pharmaceuticals
Rotech Healthcare Inc., a leading provider of home medical equipment and services in the United States, in corporate and securities matters relating to its bankruptcy, restructuring and emergence from Chapter 11 proceedings
Leerink Partners LLC in connection with a $60 million private placement and reverse merger into a public corporation by Intra-Cellular Therapies
Stuart is quoted regularly in the media regarding securities offerings and alternative financing techniques. During the past three years, he has completed over 60 registered offerings of securities totaling over $1.5 billion in proceeds. He also has represented placement agents in over 125 private placements of securities for public and private companies. In addition, Stuart has completed over 100 venture capital and other private equity transactions, representing both investors and companies seeking financing. Stuart’s experience covers a wide range of industries, including life sciences, technology, alternative energy, health care, the Internet and telecommunications. He regularly speaks and writes on topics relating to securities offerings.